Click the link to see Jason Hartman and Michael Scribner share valuable insights into our collaboration with Optima. ✅ Why Optima’s equipment was the perfect fit for our specific requirements ✅ How Optima’s Turnkey approach and the flexibility of its solutions created real added value ✅ What truly matters when building a strong, reliable, and successful partnership with Optima, we believe that close collaboration and a deep understanding of customer needs are the foundation for delivering innovative, tailored solutions that empower our partners to grow and succeed.

The Healthcare Technology Report’s Top 50 Healthcare Technology Companies of 2025 spotlights how quickly healthcare innovation is expanding across diagnostics, care delivery, clinical intelligence, and data-driven precision medicine, highlighting major breakthroughs from companies as the industry pushes toward faster, smarter, and more scalable solutions. August Bioservices was nominated as one of the key companies recognized this year, reinforcing the growing importance of advanced biomanufacturing in the healthcare technology ecosystem and underscoring August’s role in helping bring next-generation therapies from development to patients with speed, flexibility, and quality.

Intellectual property powers lifesaving innovations and therapies

Exploring innovations, challenges, and future horizons in parenteral drug delivery.

For this roundtable, Contract Pharma called upon thought leaders across the pharmaceutical services sector to address “3 Key Trends” impacting the CDMO industry in 2025 and beyond.

Bringing a sterile injectable product from development to commercialization requires a seamless scale-up process—one that minimizes risk, optimizes efficiency, and ensures regulatory success. In this exclusive webinar, experts from August Bioservices will discuss the critical factors that make or break a successful scale-up, sharing insights from a CDMO’s unique perspective.

CDMO leaders talk about navigating a dynamic landscape of innovation and demand.

Jenn Adams recognized in The Healthcare Technology Report, ” The Top 50 Women Leaders in Healthcare Technology of 2024″. In a rapidly changing and evolving industry, these executives are helping chart a course for an industry that is projected to hit $1 trillion within the next 10 years.

August Bioservices LLC has received $1 million in funding from the Tennessee Department of Economic and Community Development for machinery and additional staff. This is not the first or the last time the pharmaceutical company will be expanding.